INVA vs MDT: fair value comparison
Innoviva, Inc. and Medtronic plc · Updated 2026-10-19
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, MDT currently sits closer to the top of our ranking by discount to fair value.
| INVA | MDT | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $20.78 | $88.48 |
| 12-month range | $17.57–$24.24 | $73.75–$105.35 |
| Rank by discount to fair value | #43 of 108 Healthcare | #41 of 108 Healthcare |
| Quality grade | A | A |
| Leverage | Low | Moderate |
| Margin trend | Contracting | Expanding |
| Revenue growth | High | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Downtrend | — |
| DCF cross-check | Undervalued | Overvalued |
| 52-week position | The lower-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: INVA fair value analysis · MDT fair value analysis